1. |
Khwaja A, Bjorkholm M, Gale RE, et al. Acute myeloid leukaemia. Nat Rev Dis Primers, 2016, 10(2): 16010.
|
2. |
Guy J, Antony-Debré I, Benayoun E, et al. Flow cytometry thresholds of myeloperoxidase detection to discriminate between acute lymphoblastic or myeloblastic leukaemia. Br J Haematol, 2013, 161(4): 551-555.
|
3. |
Chen WX, Zhu HL, Xue M, et al. Quick staining technique for myeloperoxidase using potassium iodide and oxidized pyronine B. Acta Histochem, 2014, 116(1): 292-296.
|
4. |
Lee D, Grigoriadis G, Westerman D. The role of multiparametric flow cytometry in the detection of minimal residual disease in acute leukaemia. Pathology, 2015, 47(7): 609-621.
|
5. |
Sukumaran R, Nair RA, Jacob PM, et al. Flow cytometric analysis of mixed phenotype acute leukemia: experience from a tertiary oncology center. Indian J Pathol Microbiol, 2015, 58(2): 181-186.
|
6. |
刘想想, 熊北斗, 王敏, 等. 髓过氧化物酶基因多态性与白血病关系的 Meta 分析. 公共卫生与预防医学, 2016, 27(2): 5-7.
|
7. |
Döhner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. N Engl J Med, 2015, 373(12): 1136-1152.
|
8. |
胡彩虹, 杨桂斌, 张夏, 等. MICM分型在急性早幼粒细胞白血病诊断中的应用. 国际检验医学, 2013, 34(24): 3347-3348.
|
9. |
McKenna RW, Parkin J, Bloomfield CD, et al. Acute promyelocyticleukaemia: a study of 39 cases with identification of a hyperbasophilicmicrogranular variant. Br J Haematol, 1982, 50(2): 201-214.
|
10. |
Latger-Cannard V, Bardet V, Malet M, et al. Evaluation of peroxidase activity by alpha-naphthol/pyronine staining compared with benzidine staining in 101 acute leukemia cases. Lab Hematol, 2010, 16(4): 76-82.
|
11. |
常军林, 巨小英. 髓过氧化物酶染色对急性白血病分型诊断的价值. 吉林医学, 2014, 22: 4925-4926.
|
12. |
Zhou JZ. Positive rate and score discrepancies of myeloperoxidase staining at different temperatures. Acta Histochem, 2014, 116(1): 289-291.
|
13. |
Sharma A, Buxi G, Walia R, et al. Childhood acute erythroleukemia diagnosis by flow cytometry. Indian J Pathol Microbiol, 2011, 54(1): 173-175.
|
14. |
Ikoma MR, Beltrame MP, Ferreira S, et al. Proposal for the standardization of flowcytometry protocols to detect minimal residual disease in acutelymphoblastic leukemia. Rev Bras Hematol Hemoter, 2015, 37(6): 406-413.
|
15. |
Saravanan L, Juneja S. Immunohistochemistry is a more sensitive marker for the detection of myeloperoxidase in acute myeloid leukemia compared with flow cytometry and cytochemistry. Int J Lab Hematol, 2010, 32(1,1): E132-E136.
|
16. |
Manivannan P, Puri V, Somasundaram V, et al. Can threshold for MPO by flow cytometry be reduced in classifying acute leukaemia? A comparison of flowcytometric and cytochemical myeloperoxidase using different flow cytometric cut-offs. Hematology, 2015, 20(8): 455-461.
|